Rijksinstituut voor Volksgezondheid en Milieu Apigenin as a candidate prenatal treatment for Trisomy 21: effects in human amniocytes and the Ts1Cje mouse model. | RIVM Jaar: 2020 Apigenin as a candidate prenatal treatment for Trisomy 21: effects in human amniocytes and the Ts1Cje mouse model. | RIVM Bron: rivm.nl Download dossier (ZIP) · JSON